In addition, HSPB1 expression in prostate cancer cells is significantly increased after androgen deprivation and chemotherapy and acts as a molecular chaperone for cell protection, making cells resistant to drugs [32]. This evidence concerns the gene HSPB1 and Familial prostate cancer.